Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Mina Zare, Ghodratollah Panahi, Mehdi Koushki, Zohreh Mostafavi-Pour & Reza Meshkani. (2022) Metformin reduces lipid accumulation in HepG2 cells via downregulation of miR-33b. Archives of Physiology and Biochemistry 128:2, pages 333-340.
Read now
Read now
Articles from other publishers (29)
Sara Ezazi-Toroghi, Sana Abdul-Jabbar Ali, Dmitry Olegovich Bokov, Maryam Dareini, Malihe Bahadori, Parisa Mokaberi, Zeinab Amiri-Tehranizadeh, Mohammad Reza Saberi & Jamshidkhan Chamani. (2022) Interaction behavior between glycated human serum albumin and metformin in the presence of silver nanoparticles: a combination study of spectroscopic, calorimetric and molecular dynamic. Journal of the Iranian Chemical Society 19:12, pages 4569-4588.
Crossref
Crossref
Jiayao Feng, Shuting Qiu, Shipeng Zhou, Yue Tan, Yan Bai, Hua Cao, Jiao Guo & Zhengquan Su. (2022) mTOR: A Potential New Target in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 23:16, pages 9196.
Crossref
Crossref
Wenjing Liao, Suyu Liu, Yunxi Chen, Yashuai Kong, Dongxu Wang, Yijun Wang, Tiejun Ling, Zhongwen Xie, Irada Khalilova & Jinbao Huang. (2022) Effects of Keemun and Dianhong Black Tea in Alleviating Excess Lipid Accumulation in the Liver of Obese Mice: A Comparative Study. Frontiers in Nutrition 9.
Crossref
Crossref
Tao-tao Zhang, Yong Wang, Xiang-wen Zhang, Ke-yu Yang, Xiu-qin Miao & Guo-hua Zhao. (2022) MiR-200c-3p Regulates DUSP1/MAPK Pathway in the Nonalcoholic Fatty Liver After Laparoscopic Sleeve Gastrectomy. Frontiers in Endocrinology 13.
Crossref
Crossref
Carlo Smirne, Eleonora Croce, Davide Di Benedetto, Vincenzo Cantaluppi, Cristoforo Comi, Pier Paolo Sainaghi, Rosalba Minisini, Elena Grossini & Mario Pirisi. (2022) Oxidative Stress in Non-Alcoholic Fatty Liver Disease. Livers 2:1, pages 30-76.
Crossref
Crossref
Arezoo Gowhari Shabgah, Fatemeh Norouzi, Mahdiyeh Hedayati-Moghadam, Davood Soleimani, Naseh Pahlavani & Jamshid Gholizadeh Navashenaq. (2021) A comprehensive review of long non-coding RNAs in the pathogenesis and development of non-alcoholic fatty liver disease. Nutrition & Metabolism 18:1.
Crossref
Crossref
Bo Shen & Lun Gen Lu. (2021) Efficacy and safety of drugs for nonalcoholic steatohepatitis. Journal of Digestive Diseases 22:2, pages 72-82.
Crossref
Crossref
Johanna C. Arroyave-Ospina, Zongmei Wu, Yana Geng & Han Moshage. (2021) Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy. Antioxidants 10:2, pages 174.
Crossref
Crossref
Nada Saewanee, Theethawat Praputpittaya, Nawaphat Malaiwong, Pawanrat Chalorak & Krai Meemon. (2021) Neuroprotective effect of metformin on dopaminergic neurodegeneration and α-synuclein aggregation in C. elegans model of Parkinson’s disease. Neuroscience Research 162, pages 13-21.
Crossref
Crossref
Chukwuebuka H. Ozoude, Chukwuemeka P. Azubuike, Modupe O. Ologunagba, Sejoro S. Tonuewa & Cecilia I. Igwilo. (2020) Formulation and development of metformin-loaded microspheres using Khaya senegalensis (Meliaceae) gum as co-polymer. Future Journal of Pharmaceutical Sciences 6:1.
Crossref
Crossref
Kun Xie, Xi He, Keyu Chen, Kozue Sakao & De-Xing Hou. (2020) Ameliorative effects and molecular mechanisms of vine tea on western diet-induced NAFLD. Food & Function 11:7, pages 5976-5991.
Crossref
Crossref
Minjuan Ma, Rui Duan, Lulu Shen, Mengting Liu, Yaya Ji, Hao Zhou, Changxian Li, Tingming Liang, Xiangcheng Li & Li Guo. (2020) The lncRNA Gm15622 stimulates SREBP-1c expression and hepatic lipid accumulation by sponging the miR-742-3p in mice. Journal of Lipid Research 61:7, pages 1052-1064.
Crossref
Crossref
Xiaodan Lv, Yongqiang Dong, Lingling Hu, Feiyu Lu, Changyu Zhou & Shaoyou Qin. (2020) Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) for the management of nonalcoholic fatty liver disease (NAFLD): A systematic review. Endocrinology, Diabetes & Metabolism 3:3.
Crossref
Crossref
P. O. Bogomolov, A. O. Bueverov, A. V. Dreval, O. A. Nechaeva, A. Yu. Mayorov, E. E. Mishina, E. A. Fedosina, S. V. Koblov, O. V. Sumtsova, A. Jallow, D. A. Dubrovina, E. A. Troshina, K. A. Komshilova, M. V. Arapova, N. G. Vacheishvili & E. O. Liusina. (2020) Preliminary results of dulaglutide treatment in patients with non-alcoholic fatty liver disease (DEMOS study). Experimental and Clinical Gastroenterology:9, pages 4-10.
Crossref
Crossref
Seon Ju Mun, Jae-Sung Ryu, Mi-Ok Lee, Ye Seul Son, Soo Jin Oh, Hyun-Soo Cho, Mi-Young Son, Dae-Soo Kim, Su Jung Kim, Hyun Ju Yoo, Ho-Joon Lee, Janghwan Kim, Cho-Rok Jung, Kyung-Sook Chung & Myung Jin Son. (2019) Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids. Journal of Hepatology 71:5, pages 970-985.
Crossref
Crossref
Wenjia Yang, Xiaoling Cai, Haiya Wu & Linong Ji. (2019)
Associations between metformin use and vitamin B
12
levels, anemia, and neuropathy in patients with diabetes: a meta‐analysis
. Journal of Diabetes 11:9, pages 729-743.
Crossref
Crossref
Yong-li Li, Xiang-qian Li, Ya-dong Wang, Chuan Shen & Cai-yan Zhao. (2019) Metformin alleviates inflammatory response in non-alcoholic steatohepatitis by restraining signal transducer and activator of transcription 3-mediated autophagy inhibition in vitro and in vivo. Biochemical and Biophysical Research Communications 513:1, pages 64-72.
Crossref
Crossref
Eric P. Stahl, Devinder S. Dhindsa, Suegene K. Lee, Pratik B. Sandesara, Naga P. Chalasani & Laurence S. Sperling. (2019) Nonalcoholic Fatty Liver Disease and the Heart. Journal of the American College of Cardiology 73:8, pages 948-963.
Crossref
Crossref
Xiaopeng Zhu, Hongmei Yan, Mingfeng Xia, Xinxia Chang, Xi Xu, Liu Wang, Xiaoyang Sun, Yan Lu, Hua Bian, Xiaoying Li & Xin Gao. (2018) Metformin attenuates triglyceride accumulation in HepG2 cells through decreasing stearyl-coenzyme A desaturase 1 expression. Lipids in Health and Disease 17:1.
Crossref
Crossref
Qiao Wu, Juan Liu, Lijin Liu, Yu Chen, Jie Wang, Ling Leng, Qunfang Yu, Zhongping Duan & Yunfang Wang. (2018) Establishment of an ex Vivo Model of Nonalcoholic Fatty Liver Disease Using a Tissue-Engineered Liver. ACS Biomaterials Science & Engineering 4:8, pages 3016-3026.
Crossref
Crossref
Giulio Calza, Elisabeth Nyberg, Matias Mäkinen, Rabah Soliymani, Annunziata Cascone, Dan Lindholm, Emanuele Barborini, Marc Baumann, Maciej Lalowski & Ove Eriksson. (2018) Lactate-Induced Glucose Output Is Unchanged by Metformin at a Therapeutic Concentration – A Mass Spectrometry Imaging Study of the Perfused Rat Liver. Frontiers in Pharmacology 9.
Crossref
Crossref
Kunal Maniar, Amal Moideen, Ankur Mittal, Amol Patil, Amitava Chakrabarti & Dibyajyoti Banerjee. (2017) A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?. Pharmacological Research 117, pages 103-128.
Crossref
Crossref
Rong Zhang, Keran Cheng, Shizan Xu, Sainan Li, Yuqing Zhou, Shunfeng Zhou, Rui Kong, Linqiang Li, Jingjing Li, Jiao Feng, Liwei Wu, Tong Liu, Yujing Xia, Jie Lu, Chuanyong Guo & Yingqun Zhou. (2017) Metformin and Diammonium Glycyrrhizinate Enteric-Coated Capsule versus Metformin Alone versus Diammonium Glycyrrhizinate Enteric-Coated Capsule Alone in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. Gastroenterology Research and Practice 2017, pages 1-11.
Crossref
Crossref
QUELSON COELHO LISBOA, SILVIA MARINHO FEROLLA COSTA & CLÁUDIA ALVES COUTO. (2016) Current management of non-alcoholic fatty liver disease. Revista da Associação Médica Brasileira 62:9, pages 872-878.
Crossref
Crossref
Niki Katsiki, Dimitri P. Mikhailidis & Christos S. Mantzoros. (2016) Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism 65:8, pages 1109-1123.
Crossref
Crossref
Amedeo Lonardo, Silvia Sookoian, Carlos J. Pirola & Giovanni Targher. (2016) Non-alcoholic fatty liver disease and risk of cardiovascular disease. Metabolism 65:8, pages 1136-1150.
Crossref
Crossref
Peiqiu Cao, Guidong Huang, Qingyun Yang, Jiao Guo & Zhengquan Su. (2016) The effect of chitooligosaccharides on oleic acid-induced lipid accumulation in HepG 2 cells. Saudi Pharmaceutical Journal 24:3, pages 292-298.
Crossref
Crossref
Byung-Hak Kim, Songhee Han, Haeri Lee, Chi Hye Park, Young Mee Chung, Kyungmin Shin, Hyun Gyu Lee & Sang-Kyu Ye. (2015) Metformin enhances the anti-adipogenic effects of atorvastatin via modulation of STAT3 and TGF-β/Smad3 signaling. Biochemical and Biophysical Research Communications 456:1, pages 173-178.
Crossref
Crossref
Ludovico Abenavoli, Valentina Peta & Natasa Milic. (2015) Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: a case series. Annals of Hepatology 14:1, pages 121-126.
Crossref
Crossref